We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Health Canada has granted a new medical device license to NIR Diagnostics, a developer of handheld reagentless spectroscopy based medical instruments, for its HemoNIR-LAB, allowing the company to sell the device for blood testing in laboratory use only in Canada.
Guidant has begun enrollment in its SPIRIT II drug-eluting stent (DES) clinical study, a 300-patient study evaluating its Xience V everolimus-eluting coronary stent system utilizing Guidant's cobalt chromium Multi-Link Vision coronary stent system platform.
Nanogen, a developer of advanced diagnostic products, announced it was issued Patent No. 6,911,310, "Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system" by the U.S.
Applied Biosystems Group, an Applera business, and Xennex, a provider of commercial licenses for the GeneCards database of human genes, announced an agreement whereby Applied Biosystems TaqMan Genomic Assays will be accessible via GeneCards.
OphthoCare, which develops electronic eyeglasses for treating lazy eye syndrome (amblyopia) in children, obtained FDA approval to market its products in the U.S.
IMI International Medical Innovations announced a collaborative research agreement with members of the U.S. National Cancer Institute's (NCI's) Early Detection Research Network's (EDRN's) Great Lakes-New England Clinical Epidemiology Center Consortium to include IMI's ColorectAlert test in a major colorectal cancer clinical trial.
Novadaq Technologies and CarboMedics of the Sorin Group, a company specializing in medical technologies for cardiac surgery, announced that they have signed a North American agreement to distribute the SPY Intra-operative Imaging System, a real-time visual imaging device for use during coronary artery bypass graft surgery.